Sponsor Pipeline

Shanghai Longwood Biopharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07370909 Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients… Moderate to Severe Atopic Dermatitis Not Yet Recruiting
Phase 2
NCT07556471 Evaluation of the Efficacy and Safety of LW402 Tablets in Patients With Non-Segmental… Non-Segmental Vitiligo (NSV) Not Yet Recruiting
Phase 1/2
NCT07179575 Study of LW231 in Participants With Chronic Hepatitis B Chronic HBV Infection Recruiting
Disease Areas
Atopic Dermatitis (1)
Get alerts when Shanghai Longwood Biopharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free